319 related articles for article (PubMed ID: 17851013)
1. Estimation of the transition temperature for an enantiotropic polymorphic system from the transformation kinetics monitored using Raman spectroscopy.
Hu Y; Wikström H; Byrn SR; Taylor LS
J Pharm Biomed Anal; 2007 Nov; 45(4):546-51. PubMed ID: 17851013
[TBL] [Abstract][Full Text] [Related]
2. Determination of hydrate transition temperature using transformation kinetics obtained by Raman spectroscopy.
Wikström H; Kakidas C; Taylor LS
J Pharm Biomed Anal; 2009 Feb; 49(2):247-52. PubMed ID: 19112003
[TBL] [Abstract][Full Text] [Related]
3. In-line monitoring of partial and overall solid concentration during solvent-mediated phase transition using Raman spectroscopy.
Caillet A; Puel F; Fevotte G
Int J Pharm; 2006 Jan; 307(2):201-8. PubMed ID: 16303270
[TBL] [Abstract][Full Text] [Related]
4. Raman detected differential scanning calorimetry of polymorphic transformations in acetaminophen.
Kauffman JF; Batykefer LM; Tuschel DD
J Pharm Biomed Anal; 2008 Dec; 48(5):1310-5. PubMed ID: 18930622
[TBL] [Abstract][Full Text] [Related]
5. Vibrational spectroscopic characterisation of salmeterol xinafoate polymorphs and a preliminary investigation of their transformation using simultaneous in situ portable Raman spectroscopy and differential scanning calorimetry.
Ali HR; Edwards HG; Hargreaves MD; Munshi T; Scowen IJ; Telford RJ
Anal Chim Acta; 2008 Jul; 620(1-2):103-12. PubMed ID: 18558130
[TBL] [Abstract][Full Text] [Related]
6. Advanced calibration strategy for in situ quantitative monitoring of phase transition processes in suspensions using FT-Raman spectroscopy.
Chen ZP; Fevotte G; Caillet A; Littlejohn D; Morris J
Anal Chem; 2008 Sep; 80(17):6658-65. PubMed ID: 18665607
[TBL] [Abstract][Full Text] [Related]
7. Use of in situ FT-Raman spectroscopy to study the kinetics of the transformation of carbamazepine polymorphs.
O'Brien LE; Timmins P; Williams AC; York P
J Pharm Biomed Anal; 2004 Oct; 36(2):335-40. PubMed ID: 15496326
[TBL] [Abstract][Full Text] [Related]
8. Solubility of molecular crystals: polymorphism in the light of solubility theory.
Bennema P; van Eupen J; van der Wolf BM; Los JH; Meekes H
Int J Pharm; 2008 Mar; 351(1-2):74-91. PubMed ID: 17980982
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the three major polymorphic forms and liquid state of tristearin by Raman spectroscopy.
Da Silva E; Bresson S; Rousseau D
Chem Phys Lipids; 2009 Feb; 157(2):113-9. PubMed ID: 19056367
[TBL] [Abstract][Full Text] [Related]
10. Structure-property relationships in the crystals of the smallest amino acid: an incoherent inelastic neutron scattering study of the glycine polymorphs.
Bordallo HN; Boldyreva EV; Buchsteiner A; Koza MM; Landsgesell S
J Phys Chem B; 2008 Jul; 112(29):8748-59. PubMed ID: 18578525
[TBL] [Abstract][Full Text] [Related]
11. The solubility behaviour and thermodynamic relations of the three forms of Venlafaxine free base.
van Eupen JT; Westheim R; Deij MA; Meekes H; Bennema P; Vlieg E
Int J Pharm; 2009 Feb; 368(1-2):146-53. PubMed ID: 18996456
[TBL] [Abstract][Full Text] [Related]
12. Quantification of polymorphic impurity in an enantiotropic polymorph system using differential scanning calorimetry, X-ray powder diffraction and Raman spectroscopy.
Li Y; Chow PS; Tan RB
Int J Pharm; 2011 Aug; 415(1-2):110-8. PubMed ID: 21645601
[TBL] [Abstract][Full Text] [Related]
13. [Raman spectroscopic analysis of dissolution and phase transformation of chloropinnoite in the boric acid aqueous solution].
Li XP; Gao SY; Liu ZH; Hu MC; Xia SP
Guang Pu Xue Yu Guang Pu Fen Xi; 2005 Jan; 25(1):48-50. PubMed ID: 15852816
[TBL] [Abstract][Full Text] [Related]
14. Reevaluation of solubility of tolbutamide and polymorphic transformation from Form I to unknown crystal form.
Hasegawa G; Komasaka T; Bando R; Yoshihashi Y; Yonemochi E; Fujii K; Uekusa H; Terada K
Int J Pharm; 2009 Mar; 369(1-2):12-8. PubMed ID: 19026732
[TBL] [Abstract][Full Text] [Related]
15. Structural characteristics and crystal polymorphism of three local anaesthetic bases crystal polymorphism of local anaesthetic drugs: part VII.
Schmidt AC
Int J Pharm; 2005 Jul; 298(1):186-97. PubMed ID: 15955643
[TBL] [Abstract][Full Text] [Related]
16. A quantitative model to evaluate solubility relationship of polymorphs from their thermal properties.
Mao C; Pinal R; Morris KR
Pharm Res; 2005 Jul; 22(7):1149-57. PubMed ID: 16028016
[TBL] [Abstract][Full Text] [Related]
17. Molecular order and thermodynamics of the solid-liquid transition in triglycerides via Raman spectroscopy.
Da Silva E; Rousseau D
Phys Chem Chem Phys; 2008 Aug; 10(31):4606-13. PubMed ID: 18665310
[TBL] [Abstract][Full Text] [Related]
18. Transmission Raman spectroscopy as a tool for quantifying polymorphic content of pharmaceutical formulations.
Aina A; Hargreaves MD; Matousek P; Burley JC
Analyst; 2010 Sep; 135(9):2328-33. PubMed ID: 20614090
[TBL] [Abstract][Full Text] [Related]
19. Characterizing the conversion kinetics of carbamazepine polymorphs to the dihydrate in aqueous suspension using Raman spectroscopy.
Tian F; Zeitler JA; Strachan CJ; Saville DJ; Gordon KC; Rades T
J Pharm Biomed Anal; 2006 Feb; 40(2):271-80. PubMed ID: 16146681
[TBL] [Abstract][Full Text] [Related]
20. Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy.
Savolainen M; Kogermann K; Heinz A; Aaltonen J; Peltonen L; Strachan C; Yliruusi J
Eur J Pharm Biopharm; 2009 Jan; 71(1):71-9. PubMed ID: 18590816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
